CN104402979B - 一种可破坏细菌细胞壁的蛋白及其制备方法 - Google Patents
一种可破坏细菌细胞壁的蛋白及其制备方法 Download PDFInfo
- Publication number
- CN104402979B CN104402979B CN201410696091.7A CN201410696091A CN104402979B CN 104402979 B CN104402979 B CN 104402979B CN 201410696091 A CN201410696091 A CN 201410696091A CN 104402979 B CN104402979 B CN 104402979B
- Authority
- CN
- China
- Prior art keywords
- albumen
- auto2
- present
- preparation
- cell wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 44
- 210000002421 cell wall Anatomy 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 41
- 239000002773 nucleotide Substances 0.000 claims abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 3
- 239000013604 expression vector Substances 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 41
- 241000186779 Listeria monocytogenes Species 0.000 abstract description 24
- 102000004169 proteins and genes Human genes 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000003042 antagnostic effect Effects 0.000 abstract description 2
- 230000000845 anti-microbial effect Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 210000003000 inclusion body Anatomy 0.000 abstract description 2
- 101710153593 Albumin A Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- 230000001580 bacterial effect Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 210000000170 cell membrane Anatomy 0.000 description 11
- 238000001962 electrophoresis Methods 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 10
- 238000006460 hydrolysis reaction Methods 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 230000029087 digestion Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000004153 renaturation Methods 0.000 description 8
- 239000000470 constituent Substances 0.000 description 7
- 150000002460 imidazoles Chemical class 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 239000012149 elution buffer Substances 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 108090000604 Hydrolases Proteins 0.000 description 5
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 4
- 102000004157 Hydrolases Human genes 0.000 description 4
- 241000186781 Listeria Species 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 229960000907 methylthioninium chloride Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 101000588395 Bacillus subtilis (strain 168) Beta-hexosaminidase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108010059378 Endopeptidases Proteins 0.000 description 2
- 102000005593 Endopeptidases Human genes 0.000 description 2
- 108010022355 Fibroins Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710126437 N-acetylmuramyl-L-alanine amidase Proteins 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410696091.7A CN104402979B (zh) | 2014-11-26 | 2014-11-26 | 一种可破坏细菌细胞壁的蛋白及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410696091.7A CN104402979B (zh) | 2014-11-26 | 2014-11-26 | 一种可破坏细菌细胞壁的蛋白及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104402979A CN104402979A (zh) | 2015-03-11 |
CN104402979B true CN104402979B (zh) | 2017-11-21 |
Family
ID=52640657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410696091.7A Active CN104402979B (zh) | 2014-11-26 | 2014-11-26 | 一种可破坏细菌细胞壁的蛋白及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104402979B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111298477B (zh) * | 2020-03-11 | 2021-01-29 | 河南牧业经济学院 | 微生物破壁萃取系统 |
CN111748541B (zh) * | 2020-07-14 | 2023-05-26 | 江门市中心医院 | 一种产mdp的酶制剂在维持肠道稳态中的用途 |
-
2014
- 2014-11-26 CN CN201410696091.7A patent/CN104402979B/zh active Active
Non-Patent Citations (2)
Title |
---|
单增李斯特菌在蜂产品中快速检测方法的建立及其自溶素基因lmo1521的功能鉴定;张红娟;《中国优秀硕士学位论文全文数据库(电子期刊)农业科技辑》;CNKI;20130215(第02期);第21页第2段,第22页第3-4段,第23页第2段,第24页第2-3段,25页第2-6段,第26页第1段,第28页第3-4段,第29页第1段,第35页第1-3段和第46页第2段 * |
单细胞核增生李斯特菌自溶素的功能与调控;李唤弟等;《中国微生物学与免疫学杂志》;CNKI;20131231;第33卷(第12期);第964-969页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104402979A (zh) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Martinez et al. | Bacteriocin production by Bifidobacterium spp. A review | |
Allain et al. | Bile-salt-hydrolases from the probiotic strain Lactobacillus johnsonii La1 mediate anti-giardial activity in vitro and in vivo | |
Hynönen et al. | Lactobacillus surface layer proteins: structure, function and applications | |
van Der Kraan et al. | Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin | |
Macías‐Rodríguez et al. | Lactobacillus fermentum BCS87 expresses mucus‐and mucin‐binding proteins on the cell surface | |
Alvarez-Sieiro et al. | Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase | |
CN106967659A (zh) | 一种表达谷氨酸脱羧酶的无抗生素抗性重组枯草芽孢杆菌的构建及发酵方法 | |
Du et al. | Purification, characterization and mechanism of action of enterocin HDX-2, a novel class IIa bacteriocin produced by Enterococcus faecium HDX-2 | |
CN107384844A (zh) | 一种产磷脂酶d的重组大肠杆菌及其应用 | |
US20220370547A1 (en) | Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof | |
CN104830825B (zh) | 一种来源于沙门氏菌噬菌体的内溶素及其应用 | |
Kim et al. | Identification and characterization of a bacteriocin produced by an isolated Bacillus sp. SW1-1 that exhibits antibacterial activity against fish pathogens | |
WO2022257391A1 (zh) | 一株能够降解胶原蛋白的菌株及其应用 | |
CN104402979B (zh) | 一种可破坏细菌细胞壁的蛋白及其制备方法 | |
WO2007078633A2 (en) | Bacteriocin inducer peptides | |
Chen et al. | A novel bacteriocin against multiple foodborne pathogens from Lacticaseibacillus rhamnosus isolated from juice ferments: ATF perfusion-based preparation of viable cells, characterization, antibacterial and antibiofilm activity | |
Kong et al. | Effects of galactosyltransferase on EPS biosynthesis and freeze-drying resistance of Lactobacillus acidophilus NCFM | |
He et al. | Construction and analysis of food-grade Lactobacillus kefiranofaciens β-galactosidase overexpression system | |
CN105671113B (zh) | 用于大肠杆菌分泌表达重组蛋白的培养基及其制备方法 | |
WO2024130870A1 (zh) | 一株具有邻苯二甲酸酯降解能力的谷氨酸杆菌a4及其应用 | |
CN101691397B (zh) | 乳链菌肽突变体蛋白及其编码基因与应用 | |
CN103911337A (zh) | 高粘附性丁酸梭菌及其制备方法 | |
CN104804074B (zh) | 一种菌丝霉素突变体及其基因、制备方法和应用 | |
CN106834328A (zh) | 一种s‑核糖基高半胱氨酸裂解酶基因重组表达载体及其表达方法和应用 | |
Campbell | Increasing Productivity and Recovery of Paenibacillin from Producing Strains through Biotechnology Approaches |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Hangzhou City, Zhejiang province 310018 Xiasha Higher Education Park source Street No. 258 Applicant after: China Jiliang University Address before: Hangzhou City, Zhejiang province 310018 Xiasha Higher Education Park source Street No. 258 Applicant before: China Jiliang University |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Sufang Inventor after: Pan Jiarong Inventor after: Li Huandi Inventor after: Zhang Hongjuan Inventor after: Guan Feng Inventor after: Weng Xiaoyan Inventor before: Li Sufang Inventor before: Pan Jiarong Inventor before: Li Huandi Inventor before: Zhang Hongjuan Inventor before: Guan Feng |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240110 Address after: 235000 No. 8 Yifeng Road, Fenghuangshan Economic Development Zone, Huaibei City, Anhui Province Patentee after: Anhui Hanfang Biotechnology Co.,Ltd. Address before: 310018, No. 258, source street, Xiasha Higher Education Park, Hangzhou, Zhejiang Patentee before: China Jiliang University |
|
TR01 | Transfer of patent right |